Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
J Mol Microbiol Biotechnol ; 3(2): 301-8, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11321587

ABSTRACT

Natural products have been a critically important source of clinically relevant small molecule therapeutics. However, the discovery rate of novel structural classes of antimicrobial molecules has declined. Recently, increasing evidence has shown that the number of species cultivated from soil represents less than 1% of the total population, opening up the exciting possibility that these uncultured species may provide a large untapped pool from which novel natural products can be discovered. We have constructed and expressed in E. coli a BAC (bacterial artificial chromosome) library containing genomic fragments of DNA (5-120kb) isolated directly from soil organisms (S-DNA). Screening of the library resulted in the identification of several antimicrobial activities expressed by different recombinant clones. One clone (mg1.1) has been partially characterized and found to express several small molecules related to and including indirubin. These results show that genes involved in natural product synthesis can be cloned directly from S-DNA and expressed in a heterologous host, supporting the idea that this technology has the potential to provide novel natural products from the wealth of environmental microbial diversity and is a potentially important new tool for drug discovery.


Subject(s)
Anti-Bacterial Agents/biosynthesis , DNA, Bacterial/genetics , Escherichia coli/genetics , Gene Library , Phylogeny , Soil Microbiology , Amino Acid Sequence , Chromosomes, Artificial, Bacterial , DNA, Bacterial/chemistry , DNA, Bacterial/isolation & purification , DNA, Ribosomal/genetics , Enzymes/genetics , Molecular Sequence Data , Mutagenesis, Insertional , Open Reading Frames , Polymerase Chain Reaction , RNA, Ribosomal, 16S/genetics
2.
Appl Environ Microbiol ; 66(6): 2541-7, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10831436

ABSTRACT

Recent progress in molecular microbial ecology has revealed that traditional culturing methods fail to represent the scope of microbial diversity in nature, since only a small proportion of viable microorganisms in a sample are recovered by culturing techniques. To develop methods to investigate the full extent of microbial diversity, we used a bacterial artificial chromosome (BAC) vector to construct libraries of genomic DNA isolated directly from soil (termed metagenomic libraries). To date, we have constructed two such libraries, which contain more than 1 Gbp of DNA. Phylogenetic analysis of 16S rRNA gene sequences recovered from one of the libraries indicates that the BAC libraries contain DNA from a wide diversity of microbial phyla, including sequences from diverse taxa such as the low-G+C, gram-positive Acidobacterium, Cytophagales, and Proteobacteria. Initial screening of the libraries in Escherichia coli identified several clones that express heterologous genes from the inserts, confirming that the BAC vector can be used to maintain, express, and analyze environmental DNA. The phenotypes expressed by these clones include antibacterial, lipase, amylase, nuclease, and hemolytic activities. Metagenomic libraries are a powerful tool for exploring soil microbial diversity, providing access to the genetic information of uncultured soil microorganisms. Such libraries will be the basis of new initiatives to conduct genomic studies that link phylogenetic and functional information about the microbiota of environments dominated by microorganisms that are refractory to cultivation.


Subject(s)
Bacteria/classification , Bacteria/genetics , Ecosystem , Genome, Bacterial , Soil Microbiology , Amino Acid Sequence , Amylases/metabolism , Bacteria/metabolism , Chromosomes, Bacterial , Cloning, Molecular , DNA, Bacterial/analysis , DNA, Bacterial/genetics , Deoxyribonucleases/metabolism , Genes, rRNA , Genomic Library , Hemolysis , Lipase/metabolism , Molecular Sequence Data , Open Reading Frames , Phylogeny , RNA, Ribosomal, 16S/genetics
3.
Anal Biochem ; 275(1): 62-73, 1999 Nov 01.
Article in English | MEDLINE | ID: mdl-10542110

ABSTRACT

pp60(c-src) is a prototypical nonreceptor tyrosine kinase and may play a role in diseases as diverse as cancer and osteoporosis. In Src, the SH3 domain (Src homology 3) binds proteins at specific, proline-rich sequences, while the SH2 domain (Src homology 2) binds phosphotyrosine-containing sequences. Inhibition of Src SH3 and SH2 domain function is of potential therapeutic value because of their importance in signaling pathways involved in disease states. We have developed dual-wavelength fluorescent peptide probes for both the Src SH3 and the Src SH2 domains, which allow the simultaneous measurement of compounds binding to each domain in assays based on the technique of fluorescence polarization. We demonstrate the utility of these probes in a dual-binding assay (suitable for high-throughput screening) to study the interactions of various peptides with these domains, including a sequence from the rat protein p130(CAS) which has been reported to bind simultaneously to both Src SH3 and SH2 domains. Utilizing this dual-binding assay, we confirm that sequences from p130(CAS) can simultaneously bind Src via both its SH3 and its SH2 domains. We also use the dual-binding assay as an internal control to identify substances which inhibit SH3 and SH2 binding via nonspecific mechanisms.


Subject(s)
Fluorescence Polarization/methods , Fluorescent Dyes , Proteins , src Homology Domains , Animals , Crk-Associated Substrate Protein , Escherichia coli , Fluorescent Dyes/chemical synthesis , Humans , Oncogene Protein pp60(v-src)/metabolism , Phosphoproteins/metabolism , Protein Binding , Protein Conformation , Rats , Recombinant Proteins/metabolism , Retinoblastoma-Like Protein p130
4.
Bioorg Med Chem Lett ; 9(16): 2359-64, 1999 Aug 16.
Article in English | MEDLINE | ID: mdl-10476869

ABSTRACT

The structure-activity relationships (SAR) of a novel class of Src SH2 inhibitors are described. Variation at the pY+1 and pY+3 side chain positions using 2,4- and 2,5-substituted thiazoles and 1,2,4-oxadiazoles as scaffolds resulted in inhibitors that bound as well as the standard tetrapeptide Ac-pYEEI-NH2.


Subject(s)
Thiazoles/chemistry , Thiazoles/pharmacology , src Homology Domains , Structure-Activity Relationship
5.
Anal Biochem ; 247(1): 77-82, 1997 Apr 05.
Article in English | MEDLINE | ID: mdl-9126374

ABSTRACT

The tyrosine kinase pp60c.src has been implicated as being a potential therapeutic target in several human diseases including cancer and osteoporosis. An important region within this kinase is the SH2 domain (Src homology 2) which binds to phosphorylated tyrosine residues contained within specific peptide sequences. Homologous domains are found in a variety of cytoplasmic proteins and have been shown to be essential for controlling many important signaling pathways. Developing specific inhibitors of SH2 interactions would therefore be extremely useful for modulating a variety of signaling pathways and potentially be useful for the treatment of human disease. Current methodology for the development of organic molecules as drug leads requires the ability to test thousands of individual compounds or natural product extracts in biochemical assays. Such tests must be reproducible, simple, and versatile. This paper describes an assay based on fluorescence polarization for measuring the binding of compounds to the Src-SH2 domain. The assay is insensitive to changes in fluorescence intensity working even in solutions with moderate optical density and functions in the presence of up to 20% dimethyl sulfoxide. These features make it especially useful for high-throughput screening of both natural and synthetic compound libraries.


Subject(s)
Fluorescence Polarization/methods , Proto-Oncogene Proteins pp60(c-src)/metabolism , src Homology Domains , Amino Acid Sequence , Binding Sites , Binding, Competitive , Drug Design , Drug Evaluation, Preclinical , Fluorescent Dyes/chemistry , Humans , In Vitro Techniques , Kinetics , Molecular Structure , Oligopeptides/chemistry , Proto-Oncogene Proteins pp60(c-src)/chemistry , Recombinant Proteins/chemistry , Recombinant Proteins/metabolism , Signal Transduction
SELECTION OF CITATIONS
SEARCH DETAIL
...